Loramyc®
LORAMYC® 50 mg, muco‐adhesive buccal tablets.
For more information, please refer to the Summary of Product Characteristics and patient leaflet: https://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=69980852
Any report of an adverse reaction related to a Vectans Pharma drug should be made immediately by e-mail to infomed_pv@csp-epl.com.
![Image Lauriad technology2](https://www.vectanspharma.com/wp-content/uploads/2021/04/fin-page-produits-01.jpg)